BioSpace News Archive

Genexine announced top-line results from the KEYNOTE-899 phase 1b/2 clinical trial of GX-I7 in combination with pembrolizumab.

Wilmington, Delaware, United States: Human Papillomaviruses are individuals from papillomaviridae family a gathering of in excess of 150 related infections.

Wilmington, Delaware, United States: The growing inclination towards molecular diagnostics from conventional technologies has boosted all medical procedures to cut down dispatch time for results.

Wilmington, Delaware, United States: An early toxicity testing or screening is the process of safety assessment which determines the level of tissue or cell damage and maximum safe concentration of any chemical or drug.

Conjunctivitis refers to the swelling or inflammation of the conjunctiva of the eye. Viruses are among the leading causes of conjunctivitis on a global basis.

Emergence Therapeutics AG, a biopharmaceutical company developing novel antibody drug conjugates for the treatment of cancers with high unmet needs, announces the appointment of Hatem Azim, MD, PhD, as Chief Medical Officer, as of 6 June 2022.

Royal Philips announced that the exchange ratio for the dividend in shares for the year 2021 has been determined.

RARE-X announced that through the development of its new “The Power of Being Counted” Report, it has discovered that there are as many as 10,867 rare diseases, rather than the oft-reported previous estimate of 5,000-8,000.

Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced the formation of a Scientific Advisory Board (SAB) comprised of renowned leaders in neurology and neurodegenerative disease research.

KETABET™ ( Ketamine and Betaine) shown effectiveness as measured by the Clinician Administered Dissociative States Scale.